Previous 10 | Next 10 |
Bentrio® meets primary efficacy endpoint in NASAR clinical trial in seasonal allergic rhinitis Clinically relevant and statistically significant improvement in Total Nasal Symptom Score over saline nasal spray control (p = 0.012) Bentrio efficacy and tolerability rated as "good" or...
2023-05-18 17:54:10 ET Altamira Therapeutics Ltd. (CYTO) Q4 2022 Earnings Conference Call May 16, 2023 08:00 AM ET Company Participants Thomas Meyer - Founder, Chairman and Chief Executive Officer Covadonga Pañeda - Chief Operating Officer Conference Call ...
2023-05-16 07:39:37 ET Altamira Therapeutics press release ( NASDAQ: CYTO ):FY GAAP EPS of -CHF29.13. Revenue of CHF0.31M (+416.7% Y/Y). For further details see: Altamira Therapeutics GAAP EPS of -CHF29.13, revenue of CHF0.31M
Management will host an investor conference call today, May 16th, at 8 a.m. Eastern Company is advancing OligoPhore™ / SemaPhore™ platform for extrahepatic RNA delivery and efficient endosomal release; expects first research collaborations with biopharmaceutical companies in 20...
HAMILTON, BERMUDA / ACCESSWIRE / May 12, 2023 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing and commercializing RNA delivery technology for extrahepatic targets, announced that it will host its Fiscal Year 2022 Financial Results and Business Update Call on Tuesday...
2023-05-04 09:02:57 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips PacWest Bank (NASDAQ: PACW ) stock is falling hard on Thursday after the financial company said it’s exploring strategic options . According to an update from Pac...
2023-05-04 08:41:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips First Horizon (NYSE: FHN ) stock is taking a beating on Thursday after the company failed to complete its merger with TD Bank (NYSE: TD ). First Horizon ...
2023-05-04 08:19:44 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Arconic (NYSE: ARNC ) stock is on the rise Thursday following news that the company is being acquired by Apollo Global Management (NYSE: APO ). Apollo Gl...
2023-05-04 08:04:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Altamira Therapeutics (NASDAQ: CYTO ) stock is taking off on Thursday despite a lack of news from the RNA-based therapeutics company. There are no new press releases from Al...
2023-05-04 07:31:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another dive into the biggest pre-market stock movers as we check in on all of the latest news for Thursday! Moving stocks this morning are strong trading volumes, acqu...
News, Short Squeeze, Breakout and More Instantly...
Altamira Therapeutics Ltd. Company Name:
CYTO Stock Symbol:
NASDAQ Market:
Altamira Therapeutics Ltd. Website:
Hamilton, Bermuda, July 19, 2024 (GLOBE NEWSWIRE) -- Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdominal aortic aneurysm Altamira’s SemaPhore™ nanoparticles delivering SOD2 mRNA successfully to...
AZZ Inc. (AZZ) is expected to report $1.31 for Q1 2025 Express Inc. (EXPRQ) is expected to report for Q1 2025 Aeon Co. Ltd. ADR (AONNY) is expected to report for Q1 2025 Altamira Therapeutics Ltd. (CYTO) is expected to report for Q1 2024 Bassett Furniture Industries Incorporated (...
Hamilton, Bermuda, June 20, 2024 (GLOBE NEWSWIRE) -- Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedures in benign paroxysmal positional vertigo (BPPV) patients Betahistine is markete...